Maxisorp microtiter plate
Maxisorp microtiter plates are a laboratory product designed for various immunoassay applications. The plates feature a high-binding surface that helps optimize the adsorption of proteins, antibodies, and other biomolecules. They are commonly used in techniques such as enzyme-linked immunosorbent assay (ELISA) to facilitate the detection and quantification of target analytes.
Lab products found in correlation
110 protocols using maxisorp microtiter plate
Sandwich ELISA Methodology for Protein Detection
Quantifying Soluble IL-6 Receptor Levels
Evaluating NANOBODY Binding Specificity
Example 40
In order to determine binding specificity to H5, the different multivalent NANOBODIES® (VHH sequences) were tested in an ELISA binding assay in different concentrations. In short, 2 μg/ml of H5 were immobilized directly on Maxisorp microtiter plates (Nunc). Free binding sites were blocked using 4% Marvel in PBS. Next, Dilutions (1/10) of the NANOBODIES® (VHH sequences) starting with 10 pM in 100 μl 2% Marvel PBST were allowed to bind to the immobilized antigen. After incubation and a wash step, NANOBODY® (VHH sequence) binding was revealed using a rabbit-anti-VHH secondary antibody (a VHH). After a wash step the NANOBODIES® (VHH sequences) were detected with a HRP-conjugated goat-anti-rabbit antibody (GARPO). Binding specificity was determined based on OD values compared to controls (192-C4; SEQ ID NO: 163) against HRSV and 213-H7-15GS-213-H7 (SEQ ID NO: 2427) against Rabies). The multivalent NANOBODIES® (VHH sequences) show higher binding capacity than the monovalent (
Screening Hybridoma Supernatants for Anti-DBLβ3_D4 Antibodies
Serum IgG Quantification by ELISA
Glycan-Galectin Binding Assay
ELISA for Detection of pE6 Antibodies
ELISA and Immunoblot Analysis of AnAPN1
Quantification of Gluten Content
B7-H1 Nanobody Competition Assay
EXAMPLE 22
In order to determine competition efficiency of B7-H1 binding Nanobodies, the positive clones of the previous binding assay were tested in an ELISA competition assay setup.
In short, 2 μg/ml B7-H1 ectodomain (rhB7H1-Fc, R&D Systems, Minneapolis, US, Cat #156-B7) was immobilized on maxisorp microtiter plates (Nunc, Wiesbaden, Germany) and free binding sites were blocked using 4% Marvel in PBS. Next, 0.5 μg/ml of PD-1 was preincubated with a dilution series of purified Nanobody. An irrelevant Nanobody against FcgR1 (49C5) was used as a negative controle, since this Nanobody does not bind to B7-H1. Unlabelled PD-1 was used as a positive controle for competition of PD1-biotin. The results are shown in
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!